Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Goodwill & Intangibles: 2021-2025

Historic Goodwill & Intangibles for Mirum Pharmaceuticals (MIRM) over the last 4 years, with Sep 2025 value amounting to $231.9 million.

  • Mirum Pharmaceuticals' Goodwill & Intangibles fell 9.34% to $231.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.9 million, marking a year-over-year decrease of 9.34%. This contributed to the annual value of $249.8 million for FY2024, which is 1.23% down from last year.
  • According to the latest figures from Q3 2025, Mirum Pharmaceuticals' Goodwill & Intangibles is $231.9 million, which was down 2.51% from $237.9 million recorded in Q2 2025.
  • Mirum Pharmaceuticals' 5-year Goodwill & Intangibles high stood at $261.8 million for Q2 2024, and its period low was $18.5 million during Q1 2022.
  • For the 3-year period, Mirum Pharmaceuticals' Goodwill & Intangibles averaged around $214.9 million, with its median value being $249.8 million (2024).
  • In the last 5 years, Mirum Pharmaceuticals' Goodwill & Intangibles surged by 473.68% in 2023 and then decreased by 9.34% in 2025.
  • Mirum Pharmaceuticals' Goodwill & Intangibles (Quarterly) stood at $18.7 million in 2021, then surged by 214.59% to $59.0 million in 2022, then surged by 329.02% to $252.9 million in 2023, then dropped by 1.23% to $249.8 million in 2024, then declined by 9.34% to $231.9 million in 2025.
  • Its Goodwill & Intangibles was $231.9 million in Q3 2025, compared to $237.9 million in Q2 2025 and $243.8 million in Q1 2025.